| Unternehmen / Aktien | News 24 h | News 7 T | Kurs | ||
|---|---|---|---|---|---|
| TWIST BIOSCIENCE | 13 | - | -2,42 % | ||
| REGENERON PHARMACEUTICALS | 11 | 22 | -0,25 % | ||
| BIONTECH | 10 | 13 | 0,00 % | ||
| WAVE LIFE SCIENCES | 10 | 2 | 0,00 % | ||
| AQUESTIVE THERAPEUTICS | 8 | 2 | 0,00 % | ||
| CRISPR THERAPEUTICS | 5 | 1 | +0,46 % | ||
| ETON PHARMACEUTICALS | 4 | 5 | 0,00 % | ||
| HARROW | 4 | 4 | 0,00 % | ||
| AMGEN | 3 | 27 | -0,29 % | ||
| PACIFIC BIOSCIENCES OF CALIFORNIA | 3 | 3 | +0,98 % |
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 06:34 | Zink-Boom, Turnaround, Biotech-Wachstum: So profitieren Sie mit Pasinex Resources, Puma und Evotec | 195 | Kapitalerhöhungen.de | In volatilen Märkten suchen Anleger nach außergewöhnlichen Chancen. Drei Unternehmen stechen dabei heraus. Ein Rohstoffunternehmen mit außergewöhnlichen Zink-Projekten, ein Sportartikelhersteller im... ► Artikel lesen | |
| 04:26 | ABIVAX Société Anonyme (ABVX): A Bull Case Theory | 4 | Insider Monkey | ||
| 04:17 | WuXi Biologics and Vertex Sign License and Research Service Agreement for T-cell Engager | 2 | CNW | ||
| Mo | Clear Street initiates coverage on Caribou Biosciences stock with Buy rating | 1 | Investing.com | ||
| Mo | Morningstar Completes Acquisition of CRSP and Extends Relationship with Vanguard | 2 | City A.M. | ||
| Mo | Morningstar schließt Übernahme von Index-Anbieter CRSP für 365 Millionen US-Dollar ab | 3 | Investing.com Deutsch | ||
| Mo | Morningstar completes $365 million acquisition of CRSP from University of Chicago | 2 | Investing.com | ||
| Mo | Vaxcyte closes $632.5 million public offering of common stock | 2 | Investing.com | ||
| Mo | TD Cowen Bullish on KalVista Pharmaceuticals, Inc. (KALV) Ahead of Q4 Results | 2 | Insider Monkey | ||
| Mo | Oppenheimer Notes Relay Therapeutics (RLAY) Pipeline Strength in Mutant-Selective Inhibitors | 1 | Insider Monkey | ||
| Mo | Morningstar, Inc.: Morningstar Completes Acquisition of CRSP and Extends Relationship with Vanguard | 445 | Business Wire | The CRSP integration unites two trusted sources of market insight, reinforcing a shared commitment to transparency, quality, and investor-focused solutions and solidifying Morningstar's position... ► Artikel lesen | |
| Mo | Twist Bioscience Corp - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| Mo | Vaxcyte, Inc.: Vaxcyte Announces Closing of $632.5 Million Public Offering Including Full Exercise of Underwriters' Option to Purchase Additional Shares | 2 | GlobeNewswire (USA) | ||
| Mo | Terns Pharmaceuticals, Inc.: Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4) | 2 | GlobeNewswire (USA) | ||
| Mo | Candel Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | 1 | GlobeNewswire (USA) | ||
| Mo | Acadia Pharmaceuticals Inc.: Acadia Pharmaceuticals Provides Update on Regulatory Submission for Trofinetide for the Treatment of Rett Syndrome in the European Union | 231 | Business Wire | - Company expects to receive a negative opinion following oral explanation feedback and intends to request re-examination upon review of formal adoption.
Acadia Pharmaceuticals Inc. (Nasdaq: ACAD)... ► Artikel lesen | |
| Mo | Vaxcyte, Inc. - 8-K, Current Report | 3 | SEC Filings | ||
| Mo | Aquestive jumps despite receiving FDA Complete Response Letter | 1 | Seeking Alpha | ||
| Mo | CorMedix kündigt Aktienrückkaufprogramm über 75 Mio. $ an - Aktie legt zu | 5 | Investing.com Deutsch | ||
| Mo | Sanofi's venglustat demonstrates mixed results in late-stage rare disease trials | 10 | Seeking Alpha |